Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.

@article{Deykin2007CombinationTW,
  title={Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.},
  author={Aaron Deykin and Michael E. Wechsler and Homer A. Boushey and Vernon M. Chinchilli and Susan J Kunselman and Timothy John Craig and Emily A. Dimango and John V Fahy and Monica Kraft and Frank T. Leone and Stephen C. Lazarus and Robert F. Lemanske and Richard J. Martin and Gene Raymond Pesola and Stephen P. Peters and Christine A. Sorkness and Stanley J Szefler},
  journal={American journal of respiratory and critical care medicine},
  year={2007},
  volume={175 3},
  pages={
          228-34
        }
}
RATIONALE Long-acting beta-agonists (LABAs) and inhaled corticosteroids administered together appear to be complementary in terms of effects on asthma control. The elements of asthma control achieved by LABAs (improved lung function) and leukotriene receptor antagonists (LTRAs; protection against exacerbations) may be complementary as well. OBJECTIVE We sought to determine whether the combination of the LTRA montelukast and the LABA salmeterol could provide an effective therapeutic strategy… CONTINUE READING
Highly Cited
This paper has 21 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Asthma mortality and long-acting beta2-agonists in five major European countries, 1994-2004.

The Journal of asthma : official journal of the Association for the Care of Asthma • 2009
View 13 Excerpts
Method Support
Highly Influenced

Montelukast--place in therapy.

The Journal of the Association of Physicians of India • 2014

A large subgroup of mild-to-moderate asthma is persistently noneosinophilic.

American journal of respiratory and critical care medicine • 2012
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Effect of treatment with zileuton , a 5 - lipoxygenase inhibitor , in patients with asthma . A randomized controlled trial . Zileuton Clinical Trial Group

E Israel, J Cohn, L Dube, JM Drazen
JAMA • 2005

Regular vs. intermittent controller therapy for mild persistent asthma

HA Boushey, CA Sorkness, +7 authors A Deykin
N Engl J Med • 2005
View 2 Excerpts